Intestinal apolipoprotein B-48 synthesis and lymphatic cholesterol transport are lower in swine fed high fat, high cholesterol diet with soy protein than with casein.
Effects of dietary proteins on intestinal lipoproteins were studied in 8 Yorkshire swine fed a high fat, high cholesterol diet with either casein or soy protein. After 5 weeks of feeding, the casein group exhibited moderately elevated levels of serum cholesterol (334 +/- 46 mg/dl). The soy protein group showed significantly less hypercholesterolemia as compared to the casein group (122 +/- 8 mg/dl). Swine were subjected to cannulation of mesenteric lymph duct under halothane anesthesia. A single dose of 250 microCi [14C]cholesterol and 10 mCi [3H]leucine was infused into the upper jejunum 2 h after one-fifth of daily food was given. The 3-h lymphatic transport of cholesterol in casein-fed swine was significantly higher than in those fed soy protein. Triglyceride transport values were similar in the 2 groups. The [3H]leucine incorporation study revealed that transport of apo B-48 bore a significant positive relationship to transport of cholesterol in both chylomicron and VLDL fractions of mesenteric lymph. A greater apo B-48 secretion with higher specific activity was probably responsible for the greater transport of cholesterol in chylomicrons in casein-fed than in soy protein-fed swine. Similarly, the transport of lymph VLDL cholesterol in swine fed casein or soy protein paralleled the amount of accompanying apo B-48. Dietary proteins probably influence the intestinal synthesis of apo B-48 which in turn affects cholesterol transport into the lymphatics.
Ho
H T
HT
Department of Pathology, Neil Hellman Medical Research Building, Albany Medical College, NY 12208.
Kim
D N
DN
Lee
K T
KT
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D053283:Apolipoprotein B-48; D001055:Apolipoproteins B / Q000096:biosynthesis*; D001692:Biological Transport; D002364:Caseins / Q000494:pharmacology; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D015243:Cholesterol, VLDL / Q000378:metabolism*; D004041:Dietary Fats / Q000008:administration & dosage*; D004044:Dietary Proteins / Q000494:pharmacology*; D004591:Electrophoresis, Polyacrylamide Gel; D006937:Hypercholesterolemia / Q000378:metabolism; D007408:Intestinal Absorption; D008208:Lymphatic System / Q000378:metabolism*; D008297:Male; D014674:Plant Proteins, Dietary / Q000494:pharmacology; D030262:Soybean Proteins; D013025:Glycine max; D013552:Swine
D000596:Amino Acids; D053283:Apolipoprotein B-48; D001055:Apolipoproteins B; D002364:Caseins; D002791:Cholesterol, Dietary; D015243:Cholesterol, VLDL; D004041:Dietary Fats; D004044:Dietary Proteins; D014674:Plant Proteins, Dietary; D030262:Soybean Proteins